Regeneration/Tutogen Merger Creates Broad Biologic Implant Portfolio
This article was originally published in The Gray Sheet
Executive Summary
Regeneration Technologies Inc. will maintain both the BioCleanse and Tutoplast tissue sterilization processes for making biologic implants following its acquisition of Tutogen in a $263 million stock-swap deal, announced Nov. 13